Pre-treatment of OJS did not mitigate DRG activation but decreased inflammatory responses in BMDM. by Patrice Cunningham (12914917)

SU9518 decreases cell proliferation and restore normal remodeling in eNOS (−/−) mice. by Jun Yu (5904)

“…<p>(A), Lumen diameters (upper panel) of LC in SU9518 treated eNOS (−/−) mice were reduced in response to a remodeling stimulus but not in LC of vehicle treated eNOS (−/−) mice. …”

ERK3 deletion arrested oocytes at the MI stage and led to decreased spindle stability. by Sen Li (155994)

Genistein decreases mouse liver lnfection by <i>P. berghei</i> ANKA sporozoites. by Margarida Cunha-Rodrigues (65513)

Decreased projections to LP in <i>Brn3b</i> mutants occur postnatally. by Hyoseo Lee (17419987)

“…(<b>D</b>) Quantification was presented as a relative difference between the AP-covered LP area in controls and mutants (1.00 ± 0.07 for control, 0.20 ± 0.03 for cKO; <i>n</i> = 4 mice/group). …”

Poly I:C stimulation significantly decreased the number of lysozyme positive cells in enteroids. by Julie M. Davies (412514)

MALT1 inhibition in mDCs decreases cytokine production in zymosan-treated cells. by Celine Dumont (9327751)

Decreased antigen uptake by splenic and hepatic DCs following systemic IL-12 treatment. by Tim Chan (178208)

<i>Nampt</i> expression is significantly decreased in primary hepatocytes after ethanol treatment. by Xiwen Xiong (442078)

Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. by Neha Goveas (11790822)

“…Right panels; enteroendocrine cells stained with chromogranin A antibody (brown; arrowheads) in the villi. Scale bars are 100 μm. …”

PA produces motility alterations and decreased phosphorylation of p44/42 MAPK in podocytes. by Cristina Martínez-García (823460)

Decreasing neural activity in MBONs that suppress PER when activated has modest effects. by Justine Chia (5459294)

ADAM17 silencing increases adhesion and decreases migration of lymphatic endothelial cells (LEC). by Renata Mężyk-Kopeć (112354)

Increased inflammation and decreased proliferation in DSS-treated<i>Mttp-IKO</i> mice. by Yan Xie (41714)

Simvastatin decreases cerebral vasospasm of the middle cerebral artery and reduces microthromboemboli after SAH. by Mohammed Sabri (355717)

“…Representative images from immunohistochemical staining of fibrinogen show the presence of numerous microthromboembli in SAH animals treated with vehicle (arrow heads) but only few in animals treated with simvastatin either pre- or post-SAH, and none in the naïve controls. Scale bar is 100 µm. <b>D</b> and <b>E</b>. Both pre-SAH and post-SAH treatment with simvastatin significantly decrease microthromboemboli in both cerebral cortex (<i>P</i><0.001) and hippocampus (<i>P</i><0.01) as compared to vehicle treated group. …”

Exposure to low CO₂ levels decreases ER cholesterol levels. by Nityanand Bolshette (17396845)

“…<b>(B)</b> Bioluminescence recordings from the different conditions as depicted in <b>(A)</b>, the arrow indicates the time CO₂ was shifted from 5% to 1% (mean ± SE, <i>n</i> = 4 biological replicates per condition, AUC for 0 mM 0.34 ± 0.007, 1.59 ± 0.004 (<i>P</i> < 0.0001), 0.5 mM 1.00 ± 0.023, 2.68 ± 0.04 (<i>P</i> < 0.0001), 1 mM 1.66 ± 0.07, 3.34 ± 0.04 (<i>P</i> < 0.0001), 3 mM 2.06 ± 0.02, 2.79 ± 0.07 (<i>P</i> < 0.0001), 5 mM 2.02 ± 0.05, 2.43 ± 0.06 (<i>P</i> < 0.002), 7 mM 1.85 ± 0.01, 1.77 ± 0.02 (<i>P</i> < 0.02) two-sided Student’s <i>t</i> test). …”

mir-93 inhibits tumor growth and metastasis by decreasing CSCs in SUM159 cells. by Suling Liu (9555)

Hsp90 inhibition decreases the adipogenic transcriptional program without any effect on cytotoxicity. by Sébastien Desarzens (547289)

Puriton had the tendency of decreasing expressions of Th1 cell-related cytokines such as IFN- by So-Hyeon Bok (8066696)

siRNA-mediated knock-down significantly decreases MLL fusion expression levels. by Marieke H. van der Linden (706995)